Concepts (111)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Dendrimers | 9 | 2021 | 12 | 2.840 |
Why?
|
| Drug Delivery Systems | 7 | 2021 | 178 | 1.860 |
Why?
|
| Spheroids, Cellular | 2 | 2019 | 31 | 1.170 |
Why?
|
| Neoplasms | 10 | 2024 | 3065 | 1.040 |
Why?
|
| Chemokine CCL22 | 1 | 2024 | 8 | 0.950 |
Why?
|
| Dendritic Cells | 2 | 2024 | 451 | 0.920 |
Why?
|
| Drug Carriers | 5 | 2016 | 82 | 0.840 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2024 | 312 | 0.760 |
Why?
|
| Nanoparticles | 6 | 2022 | 164 | 0.710 |
Why?
|
| Metal Nanoparticles | 1 | 2019 | 31 | 0.660 |
Why?
|
| Gold | 1 | 2019 | 41 | 0.650 |
Why?
|
| Polymers | 2 | 2015 | 196 | 0.550 |
Why?
|
| Polyamines | 1 | 2016 | 37 | 0.510 |
Why?
|
| Membrane Proteins | 5 | 2025 | 1227 | 0.450 |
Why?
|
| Cell Line, Tumor | 7 | 2024 | 2586 | 0.370 |
Why?
|
| MCF-7 Cells | 2 | 2019 | 114 | 0.290 |
Why?
|
| RNA-Binding Proteins | 3 | 2024 | 280 | 0.290 |
Why?
|
| Mice | 11 | 2025 | 11851 | 0.270 |
Why?
|
| Radiation Tolerance | 2 | 2024 | 173 | 0.270 |
Why?
|
| Interferon Type I | 2 | 2024 | 186 | 0.260 |
Why?
|
| Animals | 15 | 2025 | 27528 | 0.240 |
Why?
|
| Disease Models, Animal | 4 | 2024 | 2393 | 0.230 |
Why?
|
| Drug Design | 2 | 2015 | 126 | 0.230 |
Why?
|
| Interleukin-10 | 1 | 2025 | 155 | 0.230 |
Why?
|
| Myeloid-Derived Suppressor Cells | 1 | 2024 | 26 | 0.230 |
Why?
|
| Melanoma, Experimental | 1 | 2024 | 111 | 0.230 |
Why?
|
| Probiotics | 2 | 2025 | 89 | 0.230 |
Why?
|
| Monocytes | 1 | 2025 | 221 | 0.220 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2024 | 600 | 0.210 |
Why?
|
| B7-H1 Antigen | 1 | 2024 | 278 | 0.200 |
Why?
|
| Colitis | 1 | 2025 | 247 | 0.200 |
Why?
|
| Transforming Growth Factor beta | 1 | 2023 | 326 | 0.190 |
Why?
|
| ErbB Receptors | 1 | 2024 | 499 | 0.190 |
Why?
|
| MicroRNAs | 2 | 2016 | 556 | 0.190 |
Why?
|
| Erythroid Precursor Cells | 1 | 2021 | 33 | 0.180 |
Why?
|
| Tretinoin | 1 | 2021 | 128 | 0.180 |
Why?
|
| Humans | 17 | 2024 | 89961 | 0.170 |
Why?
|
| NF-kappa B | 1 | 2023 | 469 | 0.170 |
Why?
|
| Chemoradiotherapy | 1 | 2021 | 306 | 0.160 |
Why?
|
| Nanostructures | 2 | 2017 | 79 | 0.160 |
Why?
|
| Particle Size | 2 | 2016 | 126 | 0.150 |
Why?
|
| Macrophages | 1 | 2021 | 582 | 0.150 |
Why?
|
| Tissue Distribution | 2 | 2015 | 293 | 0.150 |
Why?
|
| Diagnostic Techniques and Procedures | 1 | 2017 | 25 | 0.140 |
Why?
|
| Melanoma | 1 | 2021 | 471 | 0.140 |
Why?
|
| KB Cells | 1 | 2016 | 2 | 0.130 |
Why?
|
| Gene Transfer Techniques | 1 | 2017 | 153 | 0.130 |
Why?
|
| Cations | 1 | 2016 | 30 | 0.130 |
Why?
|
| Gene Expression Regulation, Leukemic | 1 | 2016 | 93 | 0.130 |
Why?
|
| Nanotechnology | 1 | 2016 | 68 | 0.130 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2016 | 154 | 0.130 |
Why?
|
| Leukemia, Myeloid | 1 | 2016 | 249 | 0.120 |
Why?
|
| Mice, Knockout | 3 | 2025 | 2016 | 0.120 |
Why?
|
| Lactates | 1 | 2014 | 36 | 0.120 |
Why?
|
| Folic Acid | 1 | 2014 | 63 | 0.110 |
Why?
|
| Follicle Stimulating Hormone | 1 | 2014 | 147 | 0.110 |
Why?
|
| Colorectal Neoplasms | 1 | 2021 | 980 | 0.110 |
Why?
|
| Polyethylene Glycols | 1 | 2014 | 360 | 0.100 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2016 | 799 | 0.080 |
Why?
|
| Female | 5 | 2024 | 46587 | 0.080 |
Why?
|
| Tumor Microenvironment | 2 | 2023 | 476 | 0.080 |
Why?
|
| Signal Transduction | 3 | 2025 | 3404 | 0.070 |
Why?
|
| Transcription Factor RelA | 1 | 2025 | 50 | 0.060 |
Why?
|
| Fecal Microbiota Transplantation | 1 | 2025 | 69 | 0.060 |
Why?
|
| Chemokine CXCL10 | 1 | 2024 | 22 | 0.060 |
Why?
|
| Antineoplastic Agents | 1 | 2015 | 2331 | 0.050 |
Why?
|
| Adenosine Monophosphate | 1 | 2022 | 28 | 0.050 |
Why?
|
| Myeloid Cells | 1 | 2023 | 101 | 0.050 |
Why?
|
| Zinc | 1 | 2022 | 95 | 0.050 |
Why?
|
| Cyclic AMP | 1 | 2022 | 277 | 0.050 |
Why?
|
| Mice, Inbred BALB C | 2 | 2014 | 1091 | 0.050 |
Why?
|
| Receptors, CCR2 | 1 | 2021 | 33 | 0.050 |
Why?
|
| Micelles | 1 | 2021 | 48 | 0.050 |
Why?
|
| Neoplasm Metastasis | 1 | 2024 | 1066 | 0.040 |
Why?
|
| Lipids | 1 | 2021 | 275 | 0.040 |
Why?
|
| Adaptive Immunity | 1 | 2021 | 167 | 0.040 |
Why?
|
| Transfection | 1 | 2021 | 909 | 0.040 |
Why?
|
| Endothelial Cells | 1 | 2022 | 464 | 0.040 |
Why?
|
| Administration, Oral | 1 | 2021 | 667 | 0.040 |
Why?
|
| Interferon-gamma | 1 | 2021 | 449 | 0.040 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2021 | 450 | 0.040 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2025 | 520 | 0.040 |
Why?
|
| Nerve Tissue Proteins | 1 | 2021 | 511 | 0.040 |
Why?
|
| Surface Properties | 1 | 2017 | 131 | 0.030 |
Why?
|
| Molecular Structure | 1 | 2017 | 293 | 0.030 |
Why?
|
| Transcription Factors | 1 | 2023 | 1664 | 0.030 |
Why?
|
| DNA | 1 | 2021 | 1311 | 0.030 |
Why?
|
| Immunotherapy | 1 | 2021 | 698 | 0.030 |
Why?
|
| Folic Acid Transporters | 1 | 2014 | 1 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2023 | 1983 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2016 | 520 | 0.030 |
Why?
|
| Nanomedicine | 1 | 2014 | 14 | 0.030 |
Why?
|
| Fluorescein | 1 | 2014 | 16 | 0.030 |
Why?
|
| Immobilized Proteins | 1 | 2014 | 14 | 0.030 |
Why?
|
| Acute Disease | 1 | 2016 | 846 | 0.030 |
Why?
|
| Technology, Pharmaceutical | 1 | 2014 | 33 | 0.030 |
Why?
|
| Inhibitor of Apoptosis Proteins | 1 | 2014 | 33 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2016 | 646 | 0.030 |
Why?
|
| Chemistry, Pharmaceutical | 1 | 2014 | 66 | 0.030 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2016 | 359 | 0.030 |
Why?
|
| Ovary | 1 | 2014 | 262 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2014 | 816 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2014 | 740 | 0.020 |
Why?
|
| Epigenesis, Genetic | 1 | 2016 | 521 | 0.020 |
Why?
|
| Cell Line | 1 | 2016 | 2495 | 0.020 |
Why?
|
| Cell Survival | 1 | 2014 | 983 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2016 | 1452 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2016 | 1670 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2016 | 3252 | 0.020 |
Why?
|
| Ovarian Neoplasms | 1 | 2014 | 772 | 0.020 |
Why?
|
| Mutation | 1 | 2016 | 4168 | 0.010 |
Why?
|